Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors

Frontiers in Chemistry
Muhammad AkramDaniela Schuster

Abstract

Cortisol synthase (CYP11B1) is the main enzyme for the endogenous synthesis of cortisol and its inhibition is a potential way for the treatment of diseases associated with increased cortisol levels, such as Cushing's syndrome, metabolic diseases, and delayed wound healing. Aldosterone synthase (CYP11B2) is the key enzyme for aldosterone biosynthesis and its inhibition is a promising approach for the treatment of congestive heart failure, cardiac fibrosis, and certain forms of hypertension. Both CYP11B1 and CYP11B2 are structurally very similar and expressed in the adrenal cortex. To facilitate the identification of novel inhibitors of these enzymes, ligand-based pharmacophore models of CYP11B1 and CYP11B2 inhibition were developed. A virtual screening of the SPECS database was performed with our pharmacophore queries. Biological evaluation of the selected hits lead to the discovery of three potent novel inhibitors of both CYP11B1 and CYP11B2 in the submicromolar range (compounds 8-10), one selective CYP11B1 inhibitor (Compound 11, IC50 = 2.5 μM), and one selective CYP11B2 inhibitor (compound 12, IC50 = 1.1 μM), respectively. The overall success rate of this prospective virtual screening experiment is 20.8% indicating good predi...Continue Reading

References

Jul 1, 1978·Annals of Internal Medicine·D N Orth
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T KawamotoH Imura
Nov 2, 1984·Klinische Wochenschrift·H G DörrD Knorr
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Mar 20, 1998·The Journal of Clinical Endocrinology and Metabolism·S E TaymansC A Stratakis
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jan 19, 2000·Trends in Biochemical Sciences·R W JohnstoneM J Smyth
Jul 6, 2000·Trends in Endocrinology and Metabolism : TEM·M Young, J W Funder
Jul 11, 2000·Journal of Molecular and Cellular Cardiology·P Lijnen, V Petrov
Sep 20, 2000·Current Hypertension Reports·J E Soberman, K T Weber
Mar 10, 2001·Cell·R P LiftonD S Geller
Dec 18, 2001·Journal of Inorganic Biochemistry·N V BelkinaR Bernhardt
Apr 5, 2003·Pituitary·Lynnette K Nieman
Apr 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Francesca Pecori GiraldiUNKNOWN Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Antongiulio FaggianoAnnamaria Colao
Jan 26, 2005·Journal of Chemical Information and Modeling·Gerhard Wolber, Thierry Langer
Jan 26, 2005·Journal of Chemical Information and Modeling·John J Irwin, Brian K Shoichet
Oct 26, 2005·Bioorganic & Medicinal Chemistry Letters·Sarah UlmschneiderRolf W Hartmann
Oct 16, 2007·Journal of Biochemical and Molecular Toxicology·F Peter Guengerich
Mar 18, 2010·Nature Reviews. Nephrology·Marie Briet, Ernesto L Schiffrin
Apr 30, 2010·Journal of Chemical Information and Modeling·David Rogers, Mathew Hahn
Jul 10, 2010·Bioorganic & Medicinal Chemistry Letters·Christopher M AdamsChun Zhang
Dec 7, 2010·Bioorganic & Medicinal Chemistry Letters·Christina ZimmerCarsten A Vock
Feb 9, 2011·Nature Reviews. Endocrinology·Nicholas A TritosBrooke Swearingen

❮ Previous
Next ❯

Citations

Jul 18, 2018·Frontiers in Chemistry·Benjamin KirchwegerJudith M Rollinger
Dec 4, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Livia LenziniGian Paolo Rossi

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

DecoyFinder
PAINS
FCFP
Pipeline Pilot Client
BEST
Discovery
SciFinder
FAF
ChemBioDraw Ultra
LigandScout

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.